Agree on good science and poor execution.
any exec who can’t sell a product during a pandemic is NOT even worth discussing. He needs to go…simply not worth arguing against it
i didn’t buy into ADO 10 years ago for its RATs product. So I’m not devastated by this delay. But it’s the inability to execute a strategy during a pandemic where all the regulations and frameworks were relaxed
Ann: TGA Registration Update, page-382
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(3.67%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $7.812K | 349.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 828094 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 1102151 | 4 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |